Emerging principles of conformation-based prion inheritance.
暂无分享,去创建一个
[1] C. King,et al. Supporting the structural basis of prion strains: induction and identification of [PSI] variants. , 2001, Journal of molecular biology.
[2] B Frangione,et al. Substitutions at codon 22 of Alzheimer's abeta peptide induce diverse conformational changes and apoptotic effects in human cerebral endothelial cells. , 2000, The Journal of biological chemistry.
[3] S. Prusiner,et al. Prion isolate specified allotypic interactions between the cellular and scrapie prion proteins in congenic and transgenic mice. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[4] H. Lehrach,et al. Mutant Huntingtin Promotes the Fibrillogenesis of Wild-type Huntingtin , 2003, Journal of Biological Chemistry.
[5] S. Prusiner,et al. Inherited prion disease caused by the V210I mutation , 2001, Neurology.
[6] B. Chesebro,et al. A single hamster PrP amino acid blocks conversion to protease-resistant PrP in scrapie-infected mouse neuroblastoma cells , 1995, Journal of virology.
[7] C. Dobson,et al. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases , 2002, Nature.
[8] Daniel I. C. Wang,et al. Specific aggregation of partially folded polypeptide chains: The molecular basis of inclusion body composition , 1996, Nature Biotechnology.
[9] G. Friedlander,et al. Protease-sensitive scrapie prion protein in aggregates of heterogeneous sizes. , 2002, Biochemistry.
[10] H. True,et al. A yeast prion provides a mechanism for genetic variation and phenotypic diversity , 2000, Nature.
[11] P E Fraser,et al. A kinetic model for amyloid formation in the prion diseases: importance of seeding. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[12] R. Marsh,et al. Biochemical and physical properties of the prion protein from two strains of the transmissible mink encephalopathy agent , 1992, Journal of virology.
[13] Roger Cooke,et al. Conformational variations in an infectious protein determine prion strain differences , 2004, Nature.
[14] V. Uversky,et al. Effect of familial Parkinson's disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human alpha-synuclein. , 2001, Biochemistry.
[15] J. Weissman,et al. Origins and kinetic consequences of diversity in Sup35 yeast prion fibers , 2002, Nature Structural Biology.
[16] M. Tuite,et al. The Candida albicans Sup35p protein (CaSup35p): function, prion-like behaviour and an associated polyglutamine length polymorphism. , 2002, Microbiology.
[17] G. C. Millson,et al. Scrapie produced experimentally in goats with special reference to the clinical syndrome. , 1961, Journal of comparative pathology.
[18] S. Supattapone,et al. In vitro amplification of protease-resistant prion protein requires free sulfhydryl groups. , 2003, Biochemistry.
[19] P. Zhou,et al. The PNM2 mutation in the prion protein domain of SUP35 has distinct effects on different variants of the [PSI+] prion in yeast , 1999, Current Genetics.
[20] L. Serpell,et al. Common core structure of amyloid fibrils by synchrotron X-ray diffraction. , 1997, Journal of molecular biology.
[21] J. Weissman,et al. The utility of prions. , 2002, Developmental cell.
[22] C. Cullin,et al. The mechanisms of [URE3] prion elimination demonstrate that large aggregates of Ure2p are dead‐end products , 2003, The EMBO journal.
[23] F. Cohen,et al. Solution structure of Syrian hamster prion protein rPrP(90-231). , 1999, Biochemistry.
[24] C. Dobson,et al. Amyloid fibril formation and seeding by wild-type human lysozyme and its disease-related mutational variants. , 2000, Journal of structural biology.
[25] S. Liebman,et al. Isolation of omnipotent suppressors in an [eta+] yeast strain. , 1990, Genetics.
[26] S. Prusiner,et al. Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[27] I. Mcconnell,et al. A single amino acid alteration (101L) introduced into murine PrP dramatically alters incubation time of transmissible spongiform encephalopathy , 1999, The EMBO journal.
[28] R. Riek,et al. NMR structure of the mouse prion protein domain PrP(121–231) , 1996, Nature.
[29] Kiowa S. Bower,et al. Synergistic effects of pesticides and metals on the fibrillation of alpha-synuclein: implications for Parkinson's disease. , 2002, Neurotoxicology.
[30] E. Mandelkow,et al. A nucleated assembly mechanism of Alzheimer paired helical filaments. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[31] I. Vorberg,et al. Molecular Basis of Scrapie Strain Glycoform Variation* , 2002, The Journal of Biological Chemistry.
[32] Rahul S. Rajan,et al. Specificity in intracellular protein aggregation and inclusion body formation , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[33] Y. Chernoff,et al. Multicopy SUP35 gene induces de-novo appearance of psi-like factors in the yeast Saccharomyces cerevisiae , 1993, Current Genetics.
[34] F. Cohen,et al. Prion Protein of 106 Residues Creates an Artificial Transmission Barrier for Prion Replication in Transgenic Mice , 1999, Cell.
[35] Susan Lindquist,et al. Prions as protein-based genetic elements. , 2002, Annual review of microbiology.
[36] Yoshikazu Nakamura,et al. Yeast [PSI+] "prions" that are crosstransmissible and susceptible beyond a species barrier through a quasi-prion state. , 2001, Molecular cell.
[37] C. Nierras,et al. The dominant PNM2- mutation which eliminates the psi factor of Saccharomyces cerevisiae is the result of a missense mutation in the SUP35 gene. , 1994, Genetics.
[38] J. Weissman,et al. Evidence for the prion hypothesis: induction of the yeast [PSI+] factor by in vitro- converted Sup35 protein. , 2000, Science.
[39] B. Permanne,et al. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding , 2001, Nature.
[40] M. Tranulis. Influence of the prion protein gene, Prnp, on scrapie susceptibility in sheep , 2002, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[41] S. Lindquist,et al. [PSI+], SUP35, and chaperones. , 2001, Advances in protein chemistry.
[42] H. Fraser,et al. Modification of the Pathogenesis of Scrapie in Mice by Treatment of the Agent , 1969, Nature.
[43] S. Duvezin-Caubet,et al. Amyloid aggregates of the HET-s prion protein are infectious , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[44] P. Fraser,et al. Morphology and antibody recognition of synthetic β‐amyloid peptides , 1991 .
[45] F. Cohen,et al. Strain‐specified relative conformational stability of the scrapie prion protein , 2001, Protein science : a publication of the Protein Society.
[46] U Aebi,et al. Polymorphic fibrillar assembly of human amylin. , 1997, Journal of structural biology.
[47] D A Smith,et al. Beta(2)-microglobulin and its deamidated variant, N17D form amyloid fibrils with a range of morphologies in vitro. , 2001, Journal of molecular biology.
[48] R. Wickner,et al. [URE3] as an altered URE2 protein: evidence for a prion analog in Saccharomyces cerevisiae. , 1994, Science.
[49] P. Fraser,et al. Conformation and fibrillogenesis of Alzheimer A beta peptides with selected substitution of charged residues. , 1994, Journal of molecular biology.
[50] J. Collinge,et al. Protease-resistant prion protein produced in vitro lacks detectable infectivity. , 1999, The Journal of general virology.
[51] P. Lansbury,et al. Species specificity in the cell-free conversion of prion protein to protease-resistant forms: a model for the scrapie species barrier. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[52] J. Richardson,et al. Natural β-sheet proteins use negative design to avoid edge-to-edge aggregation , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[53] G. J. Raymond,et al. Scrapie susceptibility-linked polymorphisms modulate the in vitro conversion of sheep prion protein to protease-resistant forms. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[54] Ruedi Aebersold,et al. A cellular gene encodes scrapie PrP 27-30 protein , 1985, Cell.
[55] C. Cullin,et al. The yeast prion [URE3] can be greatly induced by a functional mutated URE2 allele , 2000, The EMBO journal.
[56] K Wüthrich,et al. NMR structure of the bovine prion protein. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[57] R. Wickner,et al. Conservation of a portion of the S. cerevisiae Ure2p prion domain that interacts with the full-length protein , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[58] S. Prusiner,et al. Further purification and characterization of scrapie prions. , 1982, Biochemistry.
[59] F E Cohen,et al. Solution structure of a 142-residue recombinant prion protein corresponding to the infectious fragment of the scrapie isoform. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[60] R. Wickner,et al. Prion-Inducing Domain of Yeast Ure2p and Protease Resistance of Ure2p in Prion-Containing Cells , 1995, Science.
[61] A. Aguzzi,et al. Mice devoid of PrP are resistant to scrapie , 1993, Cell.
[62] F. Cohen,et al. Separation of scrapie prion infectivity from PrP amyloid polymers. , 1996, Journal of molecular biology.
[63] P. Lansbury,et al. Molecular determinants of amyloid deposition in Alzheimer's disease: conformational studies of synthetic beta-protein fragments. , 1990, Biochemistry.
[64] S. Paushkin,et al. In vitro propagation of the prion-like state of yeast Sup35 protein. , 1997, Science.
[65] Arthur L Horwich,et al. Deadly Conformations—Protein Misfolding in Prion Disease , 1997, Cell.
[66] Witold K. Surewicz,et al. Crystal structure of the human prion protein reveals a mechanism for oligomerization , 2002, Nature Structural Biology.
[67] M. Citron,et al. alpha-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson's disease. , 1999, The Journal of biological chemistry.
[68] R. Wickner,et al. Prion domain initiation of amyloid formation in vitro from native Ure2p. , 1999, Science.
[69] Stephen J. DeArmond,et al. Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques , 1989, Cell.
[70] Andrew F. Hill,et al. The same prion strain causes vCJD and BSE , 1997, Nature.
[71] L. Hood,et al. Structural studies of the scrapie prion protein using mass spectrometry and amino acid sequencing. , 1993, Biochemistry.
[72] S. Lindquist,et al. Nucleated conformational conversion and the replication of conformational information by a prion determinant. , 2000, Science.
[73] H. Fraser,et al. Transmission of bovine spongiform encephalopathy and scrapie to mice. , 1992, The Journal of general virology.
[74] M. Palmer,et al. Unaltered susceptibility to BSE in transgenic mice expressing human prion protein , 1995, Nature.
[75] C. Masters,et al. Evidence for and against the transmissibility of Alzheimer disease , 1980, Neurology.
[76] Vladimir N Uversky,et al. Conformational behavior of human alpha-synuclein is modulated by familial Parkinson's disease point mutations A30P and A53T. , 2002, Neurotoxicology.
[77] S. Rapoport,et al. Blood buffy coat from Alzheimer's disease patients and their relatives does not transmit spongiform encephalopathy to hamsters , 1994, Neurology.
[78] S W Liebman,et al. Role of the chaperone protein Hsp104 in propagation of the yeast prion-like factor [psi+]. , 1995, Science.
[79] L. Hood,et al. Purification and structural studies of a major scrapie prion protein , 1984, Cell.
[80] S. Lindquist,et al. Rnq1: an epigenetic modifier of protein function in yeast. , 2000, Molecular cell.
[81] J. Aiken,et al. Adaptation and Selection of Prion Protein Strain Conformations following Interspecies Transmission of Transmissible Mink Encephalopathy , 2000, Journal of Virology.
[82] S. Prusiner,et al. Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[83] S. Lindquist,et al. Strains of [PSI+] are distinguished by their efficiencies of prion‐mediated conformational conversion , 2001, The EMBO journal.
[84] R. Wickner,et al. Interactions among prions and prion “strains” in yeast , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[85] L. Serpell,et al. The protofilament substructure of amyloid fibrils. , 2000, Journal of molecular biology.
[86] R. Wetzel,et al. Specificity of abnormal assembly in immunoglobulin light chain deposition disease and amyloidosis. , 1996, Journal of molecular biology.
[87] Stanley B. Prusiner,et al. Nobel Lecture: Prions , 1998 .
[88] M. Maddelein,et al. In vivo aggregation of the HET‐s prion protein of the fungus Podospora anserina , 2001, Molecular microbiology.
[89] F. Cohen,et al. Identification of a prion protein epitope modulating transmission of bovine spongiform encephalopathy prions to transgenic mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[90] S. Prusiner,et al. A Change in the Conformation of Prions Accompanies the Emergence of a New Prion Strain , 2002, Neuron.
[91] Y. Chernoff,et al. Genesis and variability of [PSI] prion factors in Saccharomyces cerevisiae. , 1996, Genetics.
[92] S. Priola,et al. Glycosylation influences cross‐species formation of protease‐resistant prion protein , 2001, The EMBO journal.
[93] G. J. Raymond,et al. Evidence of a molecular barrier limiting susceptibility of humans, cattle and sheep to chronic wasting disease , 2000, The EMBO journal.
[94] M. Tuite,et al. The [URE3] phenotype: evidence for a soluble prion in yeast , 2002, EMBO reports.
[95] C. Weissmann,et al. A 'unified theory' of prion propagation , 1991, Nature.
[96] V. Smirnov,et al. [PSI+] prion generation in yeast: characterization of the ‘strain’ difference , 2001, Yeast.
[97] J T Finch,et al. Amyloid fibers are water-filled nanotubes , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[98] I. Mcconnell,et al. PrP gene dosage determines the timing but not the final intensity or distribution of lesions in scrapie pathology. , 1994, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.
[99] Ronald Wetzel,et al. Amyloid-like features of polyglutamine aggregates and their assembly kinetics. , 2002, Biochemistry.
[100] I. Herskowitz,et al. Induction of Distinct [URE3] Yeast Prion Strains , 2001, Molecular and Cellular Biology.
[101] J. Bernhagen,et al. Conformational transitions of islet amyloid polypeptide (IAPP) in amyloid formation in vitro. , 1999, Journal of molecular biology.
[102] F. Cohen,et al. Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein , 1995, Cell.
[103] J. Collinge,et al. BSE prions propagate as either variant CJD‐like or sporadic CJD‐like prion strains in transgenic mice expressing human prion protein , 2002, The EMBO journal.
[104] I D Campbell,et al. Amyloid fibril formation by an SH3 domain. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[105] D. Melton,et al. Changing a single amino acid in the N‐terminus of murine PrP alters TSE incubation time across three species barriers , 2001, The EMBO journal.
[106] I. Lascu,et al. The HET-s Prion Protein of the Filamentous Fungus Podospora anserina Aggregates in Vitro into Amyloid-like Fibrils* , 2002, The Journal of Biological Chemistry.
[107] S. Liebman,et al. The relationship between visible intracellular aggregates that appear after overexpression of Sup35 and the yeast prion‐like elements [PSI+] and [PIN+] , 2001, Molecular microbiology.
[108] Jonathan S Weissman,et al. Multiple Gln/Asn-Rich Prion Domains Confer Susceptibility to Induction of the Yeast [PSI+] Prion , 2001, Cell.
[109] D. Masison,et al. Antagonistic Interactions between Yeast [PSI+] and [URE3] Prions and Curing of [URE3] by Hsp70 Protein Chaperone Ssa1p but Not by Ssa2p , 2002, Molecular and Cellular Biology.
[110] P. Lansbury,et al. Non-genetic propagation of strain-specific properties of scrapie prion protein , 1995, Nature.
[111] H. Fraser,et al. The sequential development of the brain lesion of scrapie in three strains of mice. , 1968, Journal of comparative pathology.
[112] E. Coissac,et al. Conservation of the prion properties of Ure2p through evolution. , 2003, Molecular biology of the cell.
[113] F. Cohen,et al. Eight prion strains have PrPSc molecules with different conformations , 1998, Nature Medicine.
[114] R. Diaz-Avalos,et al. Protein-only transmission of three yeast prion strains , 2004, Nature.
[115] P. Lansbury,et al. Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. , 1997, Annual review of biochemistry.
[116] H. Vinters,et al. Stereochemical specificity of Alzheimer's disease β-peptide assembly , 1999 .
[117] David A Agard,et al. Structural studies of the scrapie prion protein by electron crystallography , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[118] Sofia Nyström,et al. Transmissibility of systemic amyloidosis by a prion-like mechanism , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[119] V. Jansen,et al. The kinetics of proteinase K digestion of linear prion polymers , 1999, Proceedings of the Royal Society of London. Series B: Biological Sciences.
[120] R. Wetzel. Ideas of order for amyloid fibril structure. , 2002, Structure.
[121] M. Enari,et al. Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[122] V. Uversky,et al. Certain Metals Trigger Fibrillation of Methionine-oxidized α-Synuclein* , 2003, Journal of Biological Chemistry.
[123] J R Glover,et al. Support for the Prion Hypothesis for Inheritance of a Phenotypic Trait in Yeast , 1996, Science.
[124] J. Weissman,et al. Conformational diversity in a yeast prion dictates its seeding specificity , 2001, Nature.
[125] F. Cohen,et al. Pathway Complexity of Prion Protein Assembly into Amyloid* , 2002, The Journal of Biological Chemistry.
[126] Peter T. Lansbury,et al. Kinetic Stabilization of the α-Synuclein Protofibril by a Dopamine-α-Synuclein Adduct , 2001, Science.
[127] S. Prusiner,et al. Scrapie prions aggregate to form amyloid-like birefringent rods , 1983, Cell.
[128] H. Nakanishi,et al. pH-dependent aggregate forms and conformation of Alzheimer amyloid beta-peptide (12-24). , 2002, Journal of biochemistry.
[129] J. Griffith,et al. Nature of the Scrapie Agent: Self-replication and Scrapie , 1967, Nature.
[130] M. Tuite,et al. Mechanism of inhibition of Ψ+ prion determinant propagation by a mutation of the N‐terminus of the yeast Sup35 protein , 1998, The EMBO journal.
[131] F E Cohen,et al. A conformational transition at the N terminus of the prion protein features in formation of the scrapie isoform. , 1997, Journal of molecular biology.
[132] U. Baxa,et al. Architecture of Ure2p Prion Filaments , 2003, Journal of Biological Chemistry.
[133] B. Roberts,et al. Yeast prions act as genes composed of self-propagating protein amyloids. , 2001, Advances in protein chemistry.
[134] Elena Orlova,et al. Cryo‐electron microscopy structure of an SH3 amyloid fibril and model of the molecular packing , 1999, The EMBO journal.
[135] W. K. Cullen,et al. Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo , 2002, Nature.
[136] Christopher M Dobson,et al. The behaviour of polyamino acids reveals an inverse side chain effect in amyloid structure formation , 2002, The EMBO journal.
[137] Y. Chernoff,et al. Evolutionary conservation of prion‐forming abilities of the yeast Sup35 protein , 2000, Molecular microbiology.
[138] F. Cohen,et al. Prion Protein Biology , 1998, Cell.
[139] C. Gibbs,et al. SLOW, LATENT AND TEMPERATE VIRUS INFECTIONS , 1967 .
[140] C. Dobson. Protein misfolding, evolution and disease. , 1999, Trends in biochemical sciences.
[141] F E Cohen,et al. Pathologic conformations of prion proteins. , 1998, Annual review of biochemistry.
[142] M. Tuite,et al. Translation termination efficiency can be regulated in Saccharomyces cerevisiae by environmental stress through a prion‐mediated mechanism , 1999, The EMBO journal.
[143] S. Lindquist,et al. Creating a protein-based element of inheritance. , 2000, Science.
[144] Alasdair C Steven,et al. Mechanism of inactivation on prion conversion of the Saccharomyces cerevisiae Ure2 protein , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[145] V. Coustou,et al. The protein product of the het-s heterokaryon incompatibility gene of the fungus Podospora anserina behaves as a prion analog. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[146] J. Collinge,et al. Structural mobility of the human prion protein probed by backbone hydrogen exchange , 1999, Nature Structural Biology.
[147] J. Doucet,et al. The native-like conformation of Ure2p in fibrils assembled under physiologically relevant conditions switches to an amyloid-like conformation upon heat-treatment of the fibrils. , 2003, Journal of structural biology.
[148] U Aebi,et al. Amyloid fibril formation from full-length and fragments of amylin. , 2000, Journal of structural biology.
[149] V. Smirnov,et al. The SUP35 omnipotent suppressor gene is involved in the maintenance of the non-Mendelian determinant [psi+] in the yeast Saccharomyces cerevisiae. , 1994, Genetics.
[150] C. Dobson,et al. Dependence on solution conditions of aggregation and amyloid formation by an SH3 domain. , 2001, Journal of molecular biology.
[151] Sean R. Collins,et al. Generation of prion transmission barriers by mutational control of amyloid conformations , 2003, Nature.
[152] C M Dobson,et al. Designing conditions for in vitro formation of amyloid protofilaments and fibrils. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[153] Stephen J. DeArmond,et al. Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication , 1990, Cell.
[154] T. Fujita,et al. Analysis of yeast prion aggregates with amyloid-staining compound in vivo. , 2003, Cell structure and function.
[155] F. Heppner,et al. Immune system and peripheral nerves in propagation of prions to CNS. , 2003, British medical bulletin.
[156] R J Fletterick,et al. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[157] S. Liebman,et al. Prions Affect the Appearance of Other Prions The Story of [PIN+] , 2001, Cell.
[158] J. Collinge. Prion diseases of humans and animals: their causes and molecular basis. , 2001, Annual review of neuroscience.
[159] S. Lindquist,et al. The role of conformational flexibility in prion propagation and maintenance for Sup35p , 2001, Nature Structural Biology.
[160] P. Lansbury,et al. Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. , 2003, Annual review of neuroscience.
[161] B. Roberts,et al. Heritable activity: a prion that propagates by covalent autoactivation. , 2003, Genes & development.
[162] P. Lansbury,et al. Amyloid fibrillogenesis: themes and variations. , 2000, Current opinion in structural biology.
[163] Synthetic peptide homologous to beta protein from Alzheimer disease forms amyloid-like fibrils in vitro. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[164] G. J. Raymond,et al. Strain-dependent Differences in β-Sheet Conformations of Abnormal Prion Protein* , 1998, The Journal of Biological Chemistry.
[165] R. Wickner,et al. Prion Filament Networks in [Ure3] Cells of Saccharomyces cerevisiae , 2001, The Journal of cell biology.
[166] J. Kemp,et al. Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis , 2002, Nature.
[167] M. Boguta,et al. Chaperones that cure yeast artificial [PSI +] and their prion-specific effects , 2000, Current Biology.
[168] K. Wüthrich,et al. Prion-inducing domain 2-114 of yeast Sup35 protein transforms in vitro into amyloid-like filaments. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[169] Y. Chernoff,et al. Yeast prion protein derivative defective in aggregate shearing and production of new ‘seeds’ , 2001, The EMBO journal.
[170] R. Somerville,et al. Characterization of Thermodynamic Diversity between Transmissible Spongiform Encephalopathy Agent Strains and Its Theoretical Implications* , 2002, The Journal of Biological Chemistry.
[171] A. Miranker,et al. Islet amyloid: phase partitioning and secondary nucleation are central to the mechanism of fibrillogenesis. , 2002, Biochemistry.
[172] K. Fischbeck,et al. Toxic Proteins in Neurodegenerative Disease , 2002, Science.
[173] S. Paushkin,et al. Propagation of the yeast prion‐like [psi+] determinant is mediated by oligomerization of the SUP35‐encoded polypeptide chain release factor. , 1996, The EMBO journal.
[174] G P Bates,et al. Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: implications for Huntington's disease pathology. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[175] P. Lantos,et al. Species-barrier-independent prion replication in apparently resistant species. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[176] J. Weissman,et al. Molecular Basis of a Yeast Prion Species Barrier , 2000, Cell.
[177] M. Ter‐Avanesyan,et al. Prion properties of the Sup35 protein of yeast Pichia methanolica , 2000, The EMBO journal.
[178] A. Hofman,et al. A new variant of Creutzfeldt-Jakob disease in the UK , 1996, The Lancet.
[179] S. Prusiner,et al. Evidence for the Conformation of the Pathologic Isoform of the Prion Protein Enciphering and Propagating Prion Diversity , 1996, Science.
[180] S. Lindquist,et al. The yeast non‐Mendelian factor [ETA+] is a variant of [PSI+], a prion‐like form of release factor eRF3 , 1999, The EMBO journal.
[181] E. Kandel,et al. A Neuronal Isoform of the Aplysia CPEB Has Prion-Like Properties , 2003, Cell.
[182] J. Kelly,et al. Alternative conformations of amyloidogenic proteins govern their behavior. , 1996, Current opinion in structural biology.
[183] S. Lindquist,et al. Self-Seeded Fibers Formed by Sup35, the Protein Determinant of [PSI +], a Heritable Prion-like Factor of S. cerevisiae , 1997, Cell.
[184] R. Kimberlin,et al. Temporary and permanent modifications to a single strain of mouse scrapie on transmission to rats and hamsters. , 1987, The Journal of general virology.
[185] A. Aguzzi,et al. High Prion and PrPSc Levels but Delayed Onset of Disease in Scrapie-Inoculated Mice Heterozygous for a Disrupted PrP Gene , 1994, Molecular medicine.
[186] J. Weissman,et al. A Critical Role for Amino-Terminal Glutamine/Asparagine Repeats in the Formation and Propagation of a Yeast Prion , 1998, Cell.
[187] B. Chesebro,et al. Identification of scrapie prion protein-specific mRNA in scrapie-infected and uninfected brain , 1985, Nature.
[188] D. Selkoe,et al. Translating cell biology into therapeutic advances in Alzheimer's disease , 1999, Nature.
[189] S. Lindquist,et al. Hsp104, Hsp70, and Hsp40 A Novel Chaperone System that Rescues Previously Aggregated Proteins , 1998, Cell.
[190] D. Thirumalai,et al. Emerging ideas on the molecular basis of protein and peptide aggregation. , 2003, Current opinion in structural biology.
[191] S. Prusiner,et al. Transmission of Creutzfeldt-Jakob disease from humans to transgenic mice expressing chimeric human-mouse prion protein. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[192] E. M. Jones,et al. Nucleation-dependent conformational conversion of the Y145Stop variant of human prion protein: Structural clues for prion propagation , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[193] S. Liebman,et al. Dependence and independence of [PSI+] and [PIN+]: a two‐prion system in yeast? , 2000, The EMBO journal.
[194] Andrew F. Hill,et al. Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD , 1996, Nature.
[195] S. Supattapone,et al. RNA molecules stimulate prion protein conversion , 2003, Nature.
[196] P. Lansbury,et al. Cell-free formation of protease-resistant prion protein , 1994, Nature.
[197] S. Prusiner,et al. Identification of a protein that purifies with the scrapie prion. , 1982, Science.
[198] J. Rossier,et al. Transmission of the BSE Agent to Mice in the Absence of Detectable Abnormal Prion Protein , 1997, Science.
[199] B. Chesebro,et al. A View from the Top--Prion Diseases from 10,000 Feet , 2003, Science.
[200] M. Baldwin. Mass spectrometric analysis of prion proteins. , 2001, Advances in protein chemistry.
[201] H. Fraser,et al. The disease characteristics of different strains of scrapie in Sinc congenic mouse lines: implications for the nature of the agent and host control of pathogenesis. , 1991, The Journal of general virology.